Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19

Societal disruption from the COVID-19 pandemic has accelerated the opioid overdose epidemic. Given the drastic increase in opioid overdose deaths during the pandemic, particularly within Black communities,1 it is important to reflect on the state of opioid addiction treatment in the United States. W...

Full description

Saved in:
Bibliographic Details
Published in:American journal of public health (1971) 2022-04, Vol.112 (S2), p.S112-S116
Main Authors: Suen, Leslie W, Coe, William H, Wyatt, Janan P, Adams, Zoe M, Gandhi, Mona, Batchelor, Hannah M, Castellanos, Stacy, Joshi, Neena, Satterwhite, Shannon, Pérez-Rodríguez, Rafael, Rodríguez-Guerra, Esther, Albizu-Garcia, Carmen E, Knight, Kelly R, Jordan, Ayana
Format: Article
Language:English
Subjects:
Adaptation
Addictions
Coronaviruses
COVID-19
Crime
Drug abuse
Drug addiction
Drug dosages
Drug overdose
Drug policy
Drug use
Drugs
Epidemics
Health services
Homeless people
Housing
Humans
Infections
Maintenance
Management
Medicaid
Mental health
Mental health services
Methadone
Methadone - therapeutic use
Monetary incentives
Mortality rates
Narcotics
Opiate Substitution Treatment
Opioid-Related Disorders - drug therapy
Opioids
Overdose
Pandemics
Patient safety
Policies
Public health
Quarantine
Racism
Regulation
Regulatory reform
Reimbursement
Scapegoating
Severe acute respiratory syndrome coronavirus 2
Social disorganization
State government
Substance abuse
Substance abuse treatment
Substance use
Substance use disorder
Telemedicine
Treatment programs
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c369t-fc0b2e6f1860dda925bea416a66e5f1043d5933656ab9d1b06f1754b272a8f793
cites cdi_FETCH-LOGICAL-c369t-fc0b2e6f1860dda925bea416a66e5f1043d5933656ab9d1b06f1754b272a8f793
container_end_page S116
container_issue S2
container_start_page S112
container_title American journal of public health (1971)
container_volume 112
creator Suen, Leslie W
Coe, William H
Wyatt, Janan P
Adams, Zoe M
Gandhi, Mona
Batchelor, Hannah M
Castellanos, Stacy
Joshi, Neena
Satterwhite, Shannon
Pérez-Rodríguez, Rafael
Rodríguez-Guerra, Esther
Albizu-Garcia, Carmen E
Knight, Kelly R
Jordan, Ayana
description Societal disruption from the COVID-19 pandemic has accelerated the opioid overdose epidemic. Given the drastic increase in opioid overdose deaths during the pandemic, particularly within Black communities,1 it is important to reflect on the state of opioid addiction treatment in the United States. When COVID-19 was declared a public health emergency, more than 400 000 individuals were receiving methadone maintenance treatment (MMT) for opioid use disorder (OUD) across the 50 states, the District of Columbia, and US territories including Puerto Rico.2 Individuals receiving MMT, a gold standard for OUD treatment, have lower rates of death and nonprescribed opioid use than those not receiving treatment and exhibit better treatment retention.3Despite these benefits, many structural barriers exist in accessing MMT, in large part because of decades of racist policies and political scapegoating (e.g., criminalizing those with substance use disorders and being "tough on crime" through harsh drug policies for political gain).4 Methadone dispensing is tightly regulated, and the medication can be dispensed only at opioid treatment programs (OTPs) overseen by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Drug Enforcement Administration, and state governments. When used in the treatment of OUD, no other prescription medication is as tightly regulated as methadone.
doi_str_mv 10.2105/AJPH.2021.306654
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2647725170</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2647725170</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-fc0b2e6f1860dda925bea416a66e5f1043d5933656ab9d1b06f1754b272a8f793</originalsourceid><addsrcrecordid>eNo9kE1PGzEQhq2qqATovafKUs-bjj83PkYBGhAolQi9rmbXs2UpsVPbe-DQ_96NQnua0eh535Eexj4JmEsB5uvy9vt6LkGKuQJrjX7HZsJoUQHoxXs2A3Aw7cqesrOcnwGEcEZ8YKfKKO2U1DP256GksStjwhe-9LgvWIYYMi-R31N5Qh8D8XscQqGAoSO-TYRlR6FwDJ5v8RdV67gjfhnzEH7yPia-2Q9x8PwxT9chx-Qp8SHw8kT8KiGPPV9tftxcVsJdsJMeXzJ9fJvn7PH6artaV3ebbzer5V3VKetK1XfQSrK9WFjwHp00LaEWFq0l0wvQyhunlDUWW-dFCxNaG93KWuKir506Z1-OvfsUf4-US_McxxSml420uq6lETVMFBypLsWcE_XNPg07TK-NgObguzn4bg6-m6PvKfL5rXhsd-T_B_4JVn8BC_l6AA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2647725170</pqid></control><display><type>article</type><title>Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19</title><source>EBSCOhost Business Source Ultimate</source><source>ABI/INFORM Collection</source><source>Social Science Premium Collection</source><source>American Public Health Association</source><source>Politics Collection</source><source>PAIS Index</source><source>PubMed Central</source><source>Sociological Abstracts</source><source>SPORTDiscus with Full Text</source><creator>Suen, Leslie W ; Coe, William H ; Wyatt, Janan P ; Adams, Zoe M ; Gandhi, Mona ; Batchelor, Hannah M ; Castellanos, Stacy ; Joshi, Neena ; Satterwhite, Shannon ; Pérez-Rodríguez, Rafael ; Rodríguez-Guerra, Esther ; Albizu-Garcia, Carmen E ; Knight, Kelly R ; Jordan, Ayana</creator><creatorcontrib>Suen, Leslie W ; Coe, William H ; Wyatt, Janan P ; Adams, Zoe M ; Gandhi, Mona ; Batchelor, Hannah M ; Castellanos, Stacy ; Joshi, Neena ; Satterwhite, Shannon ; Pérez-Rodríguez, Rafael ; Rodríguez-Guerra, Esther ; Albizu-Garcia, Carmen E ; Knight, Kelly R ; Jordan, Ayana</creatorcontrib><description>Societal disruption from the COVID-19 pandemic has accelerated the opioid overdose epidemic. Given the drastic increase in opioid overdose deaths during the pandemic, particularly within Black communities,1 it is important to reflect on the state of opioid addiction treatment in the United States. When COVID-19 was declared a public health emergency, more than 400 000 individuals were receiving methadone maintenance treatment (MMT) for opioid use disorder (OUD) across the 50 states, the District of Columbia, and US territories including Puerto Rico.2 Individuals receiving MMT, a gold standard for OUD treatment, have lower rates of death and nonprescribed opioid use than those not receiving treatment and exhibit better treatment retention.3Despite these benefits, many structural barriers exist in accessing MMT, in large part because of decades of racist policies and political scapegoating (e.g., criminalizing those with substance use disorders and being "tough on crime" through harsh drug policies for political gain).4 Methadone dispensing is tightly regulated, and the medication can be dispensed only at opioid treatment programs (OTPs) overseen by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Drug Enforcement Administration, and state governments. When used in the treatment of OUD, no other prescription medication is as tightly regulated as methadone.</description><identifier>ISSN: 0090-0036</identifier><identifier>EISSN: 1541-0048</identifier><identifier>DOI: 10.2105/AJPH.2021.306654</identifier><identifier>PMID: 35349324</identifier><language>eng</language><publisher>United States: American Public Health Association</publisher><subject>Adaptation ; Addictions ; Coronaviruses ; COVID-19 ; Crime ; Drug abuse ; Drug addiction ; Drug dosages ; Drug overdose ; Drug policy ; Drug use ; Drugs ; Epidemics ; Health services ; Homeless people ; Housing ; Humans ; Infections ; Maintenance ; Management ; Medicaid ; Mental health ; Mental health services ; Methadone ; Methadone - therapeutic use ; Monetary incentives ; Mortality rates ; Narcotics ; Opiate Substitution Treatment ; Opioid-Related Disorders - drug therapy ; Opioids ; Overdose ; Pandemics ; Patient safety ; Policies ; Public health ; Quarantine ; Racism ; Regulation ; Regulatory reform ; Reimbursement ; Scapegoating ; Severe acute respiratory syndrome coronavirus 2 ; Social disorganization ; State government ; Substance abuse ; Substance abuse treatment ; Substance use ; Substance use disorder ; Telemedicine ; Treatment programs</subject><ispartof>American journal of public health (1971), 2022-04, Vol.112 (S2), p.S112-S116</ispartof><rights>Copyright American Public Health Association Apr 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-fc0b2e6f1860dda925bea416a66e5f1043d5933656ab9d1b06f1754b272a8f793</citedby><cites>FETCH-LOGICAL-c369t-fc0b2e6f1860dda925bea416a66e5f1043d5933656ab9d1b06f1754b272a8f793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2647725170/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2647725170?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>315,786,790,4014,11715,21415,21422,27377,27899,27957,27958,33646,33809,34020,36095,43768,43983,44398,74578,74825,75252</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35349324$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suen, Leslie W</creatorcontrib><creatorcontrib>Coe, William H</creatorcontrib><creatorcontrib>Wyatt, Janan P</creatorcontrib><creatorcontrib>Adams, Zoe M</creatorcontrib><creatorcontrib>Gandhi, Mona</creatorcontrib><creatorcontrib>Batchelor, Hannah M</creatorcontrib><creatorcontrib>Castellanos, Stacy</creatorcontrib><creatorcontrib>Joshi, Neena</creatorcontrib><creatorcontrib>Satterwhite, Shannon</creatorcontrib><creatorcontrib>Pérez-Rodríguez, Rafael</creatorcontrib><creatorcontrib>Rodríguez-Guerra, Esther</creatorcontrib><creatorcontrib>Albizu-Garcia, Carmen E</creatorcontrib><creatorcontrib>Knight, Kelly R</creatorcontrib><creatorcontrib>Jordan, Ayana</creatorcontrib><title>Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19</title><title>American journal of public health (1971)</title><addtitle>Am J Public Health</addtitle><description>Societal disruption from the COVID-19 pandemic has accelerated the opioid overdose epidemic. Given the drastic increase in opioid overdose deaths during the pandemic, particularly within Black communities,1 it is important to reflect on the state of opioid addiction treatment in the United States. When COVID-19 was declared a public health emergency, more than 400 000 individuals were receiving methadone maintenance treatment (MMT) for opioid use disorder (OUD) across the 50 states, the District of Columbia, and US territories including Puerto Rico.2 Individuals receiving MMT, a gold standard for OUD treatment, have lower rates of death and nonprescribed opioid use than those not receiving treatment and exhibit better treatment retention.3Despite these benefits, many structural barriers exist in accessing MMT, in large part because of decades of racist policies and political scapegoating (e.g., criminalizing those with substance use disorders and being "tough on crime" through harsh drug policies for political gain).4 Methadone dispensing is tightly regulated, and the medication can be dispensed only at opioid treatment programs (OTPs) overseen by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Drug Enforcement Administration, and state governments. When used in the treatment of OUD, no other prescription medication is as tightly regulated as methadone.</description><subject>Adaptation</subject><subject>Addictions</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Crime</subject><subject>Drug abuse</subject><subject>Drug addiction</subject><subject>Drug dosages</subject><subject>Drug overdose</subject><subject>Drug policy</subject><subject>Drug use</subject><subject>Drugs</subject><subject>Epidemics</subject><subject>Health services</subject><subject>Homeless people</subject><subject>Housing</subject><subject>Humans</subject><subject>Infections</subject><subject>Maintenance</subject><subject>Management</subject><subject>Medicaid</subject><subject>Mental health</subject><subject>Mental health services</subject><subject>Methadone</subject><subject>Methadone - therapeutic use</subject><subject>Monetary incentives</subject><subject>Mortality rates</subject><subject>Narcotics</subject><subject>Opiate Substitution Treatment</subject><subject>Opioid-Related Disorders - drug therapy</subject><subject>Opioids</subject><subject>Overdose</subject><subject>Pandemics</subject><subject>Patient safety</subject><subject>Policies</subject><subject>Public health</subject><subject>Quarantine</subject><subject>Racism</subject><subject>Regulation</subject><subject>Regulatory reform</subject><subject>Reimbursement</subject><subject>Scapegoating</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Social disorganization</subject><subject>State government</subject><subject>Substance abuse</subject><subject>Substance abuse treatment</subject><subject>Substance use</subject><subject>Substance use disorder</subject><subject>Telemedicine</subject><subject>Treatment programs</subject><issn>0090-0036</issn><issn>1541-0048</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>7TQ</sourceid><sourceid>ALSLI</sourceid><sourceid>BHHNA</sourceid><sourceid>DPSOV</sourceid><sourceid>M0C</sourceid><sourceid>M2R</sourceid><recordid>eNo9kE1PGzEQhq2qqATovafKUs-bjj83PkYBGhAolQi9rmbXs2UpsVPbe-DQ_96NQnua0eh535Eexj4JmEsB5uvy9vt6LkGKuQJrjX7HZsJoUQHoxXs2A3Aw7cqesrOcnwGEcEZ8YKfKKO2U1DP256GksStjwhe-9LgvWIYYMi-R31N5Qh8D8XscQqGAoSO-TYRlR6FwDJ5v8RdV67gjfhnzEH7yPia-2Q9x8PwxT9chx-Qp8SHw8kT8KiGPPV9tftxcVsJdsJMeXzJ9fJvn7PH6artaV3ebbzer5V3VKetK1XfQSrK9WFjwHp00LaEWFq0l0wvQyhunlDUWW-dFCxNaG93KWuKir506Z1-OvfsUf4-US_McxxSml420uq6lETVMFBypLsWcE_XNPg07TK-NgObguzn4bg6-m6PvKfL5rXhsd-T_B_4JVn8BC_l6AA</recordid><startdate>202204</startdate><enddate>202204</enddate><creator>Suen, Leslie W</creator><creator>Coe, William H</creator><creator>Wyatt, Janan P</creator><creator>Adams, Zoe M</creator><creator>Gandhi, Mona</creator><creator>Batchelor, Hannah M</creator><creator>Castellanos, Stacy</creator><creator>Joshi, Neena</creator><creator>Satterwhite, Shannon</creator><creator>Pérez-Rodríguez, Rafael</creator><creator>Rodríguez-Guerra, Esther</creator><creator>Albizu-Garcia, Carmen E</creator><creator>Knight, Kelly R</creator><creator>Jordan, Ayana</creator><general>American Public Health Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>7RV</scope><scope>7TQ</scope><scope>7U3</scope><scope>7U4</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>88J</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHHNA</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DHY</scope><scope>DON</scope><scope>DPSOV</scope><scope>DWI</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KC-</scope><scope>L.-</scope><scope>L.0</scope><scope>LK8</scope><scope>M0C</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2L</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M2R</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PATMY</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>S0X</scope><scope>WZK</scope></search><sort><creationdate>202204</creationdate><title>Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19</title><author>Suen, Leslie W ; Coe, William H ; Wyatt, Janan P ; Adams, Zoe M ; Gandhi, Mona ; Batchelor, Hannah M ; Castellanos, Stacy ; Joshi, Neena ; Satterwhite, Shannon ; Pérez-Rodríguez, Rafael ; Rodríguez-Guerra, Esther ; Albizu-Garcia, Carmen E ; Knight, Kelly R ; Jordan, Ayana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-fc0b2e6f1860dda925bea416a66e5f1043d5933656ab9d1b06f1754b272a8f793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adaptation</topic><topic>Addictions</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Crime</topic><topic>Drug abuse</topic><topic>Drug addiction</topic><topic>Drug dosages</topic><topic>Drug overdose</topic><topic>Drug policy</topic><topic>Drug use</topic><topic>Drugs</topic><topic>Epidemics</topic><topic>Health services</topic><topic>Homeless people</topic><topic>Housing</topic><topic>Humans</topic><topic>Infections</topic><topic>Maintenance</topic><topic>Management</topic><topic>Medicaid</topic><topic>Mental health</topic><topic>Mental health services</topic><topic>Methadone</topic><topic>Methadone - therapeutic use</topic><topic>Monetary incentives</topic><topic>Mortality rates</topic><topic>Narcotics</topic><topic>Opiate Substitution Treatment</topic><topic>Opioid-Related Disorders - drug therapy</topic><topic>Opioids</topic><topic>Overdose</topic><topic>Pandemics</topic><topic>Patient safety</topic><topic>Policies</topic><topic>Public health</topic><topic>Quarantine</topic><topic>Racism</topic><topic>Regulation</topic><topic>Regulatory reform</topic><topic>Reimbursement</topic><topic>Scapegoating</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Social disorganization</topic><topic>State government</topic><topic>Substance abuse</topic><topic>Substance abuse treatment</topic><topic>Substance use</topic><topic>Substance use disorder</topic><topic>Telemedicine</topic><topic>Treatment programs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suen, Leslie W</creatorcontrib><creatorcontrib>Coe, William H</creatorcontrib><creatorcontrib>Wyatt, Janan P</creatorcontrib><creatorcontrib>Adams, Zoe M</creatorcontrib><creatorcontrib>Gandhi, Mona</creatorcontrib><creatorcontrib>Batchelor, Hannah M</creatorcontrib><creatorcontrib>Castellanos, Stacy</creatorcontrib><creatorcontrib>Joshi, Neena</creatorcontrib><creatorcontrib>Satterwhite, Shannon</creatorcontrib><creatorcontrib>Pérez-Rodríguez, Rafael</creatorcontrib><creatorcontrib>Rodríguez-Guerra, Esther</creatorcontrib><creatorcontrib>Albizu-Garcia, Carmen E</creatorcontrib><creatorcontrib>Knight, Kelly R</creatorcontrib><creatorcontrib>Jordan, Ayana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>PAIS Index</collection><collection>Social Services Abstracts</collection><collection>Sociological Abstracts (pre-2017)</collection><collection>ABI商业信息数据库</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Agriculture &amp; Environmental Science Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Business Premium Collection</collection><collection>Sociological Abstracts</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>Politics Collection</collection><collection>Sociological Abstracts</collection><collection>ProQuest Central</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Politics Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>Biological Sciences</collection><collection>ABI/INFORM Collection</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Political Science Database (Proquest)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest research library</collection><collection>ProQuest Science Journals</collection><collection>Social Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Environmental Science Database</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Sociological Abstracts (Ovid)</collection><jtitle>American journal of public health (1971)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suen, Leslie W</au><au>Coe, William H</au><au>Wyatt, Janan P</au><au>Adams, Zoe M</au><au>Gandhi, Mona</au><au>Batchelor, Hannah M</au><au>Castellanos, Stacy</au><au>Joshi, Neena</au><au>Satterwhite, Shannon</au><au>Pérez-Rodríguez, Rafael</au><au>Rodríguez-Guerra, Esther</au><au>Albizu-Garcia, Carmen E</au><au>Knight, Kelly R</au><au>Jordan, Ayana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19</atitle><jtitle>American journal of public health (1971)</jtitle><addtitle>Am J Public Health</addtitle><date>2022-04</date><risdate>2022</risdate><volume>112</volume><issue>S2</issue><spage>S112</spage><epage>S116</epage><pages>S112-S116</pages><issn>0090-0036</issn><eissn>1541-0048</eissn><abstract>Societal disruption from the COVID-19 pandemic has accelerated the opioid overdose epidemic. Given the drastic increase in opioid overdose deaths during the pandemic, particularly within Black communities,1 it is important to reflect on the state of opioid addiction treatment in the United States. When COVID-19 was declared a public health emergency, more than 400 000 individuals were receiving methadone maintenance treatment (MMT) for opioid use disorder (OUD) across the 50 states, the District of Columbia, and US territories including Puerto Rico.2 Individuals receiving MMT, a gold standard for OUD treatment, have lower rates of death and nonprescribed opioid use than those not receiving treatment and exhibit better treatment retention.3Despite these benefits, many structural barriers exist in accessing MMT, in large part because of decades of racist policies and political scapegoating (e.g., criminalizing those with substance use disorders and being "tough on crime" through harsh drug policies for political gain).4 Methadone dispensing is tightly regulated, and the medication can be dispensed only at opioid treatment programs (OTPs) overseen by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Drug Enforcement Administration, and state governments. When used in the treatment of OUD, no other prescription medication is as tightly regulated as methadone.</abstract><cop>United States</cop><pub>American Public Health Association</pub><pmid>35349324</pmid><doi>10.2105/AJPH.2021.306654</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0090-0036
ispartof American journal of public health (1971), 2022-04, Vol.112 (S2), p.S112-S116
issn 0090-0036
1541-0048
language eng
recordid cdi_proquest_journals_2647725170
source EBSCOhost Business Source Ultimate; ABI/INFORM Collection; Social Science Premium Collection; American Public Health Association; Politics Collection; PAIS Index; PubMed Central; Sociological Abstracts; SPORTDiscus with Full Text
subjects Adaptation
Addictions
Coronaviruses
COVID-19
Crime
Drug abuse
Drug addiction
Drug dosages
Drug overdose
Drug policy
Drug use
Drugs
Epidemics
Health services
Homeless people
Housing
Humans
Infections
Maintenance
Management
Medicaid
Mental health
Mental health services
Methadone
Methadone - therapeutic use
Monetary incentives
Mortality rates
Narcotics
Opiate Substitution Treatment
Opioid-Related Disorders - drug therapy
Opioids
Overdose
Pandemics
Patient safety
Policies
Public health
Quarantine
Racism
Regulation
Regulatory reform
Reimbursement
Scapegoating
Severe acute respiratory syndrome coronavirus 2
Social disorganization
State government
Substance abuse
Substance abuse treatment
Substance use
Substance use disorder
Telemedicine
Treatment programs
title Structural Adaptations to Methadone Maintenance Treatment and Take-Home Dosing for Opioid Use Disorder in the Era of COVID-19
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-24T04%3A30%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20Adaptations%20to%20Methadone%20Maintenance%20Treatment%20and%20Take-Home%20Dosing%20for%20Opioid%20Use%20Disorder%20in%20the%20Era%20of%20COVID-19&rft.jtitle=American%20journal%20of%20public%20health%20(1971)&rft.au=Suen,%20Leslie%20W&rft.date=2022-04&rft.volume=112&rft.issue=S2&rft.spage=S112&rft.epage=S116&rft.pages=S112-S116&rft.issn=0090-0036&rft.eissn=1541-0048&rft_id=info:doi/10.2105/AJPH.2021.306654&rft_dat=%3Cproquest_cross%3E2647725170%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c369t-fc0b2e6f1860dda925bea416a66e5f1043d5933656ab9d1b06f1754b272a8f793%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2647725170&rft_id=info:pmid/35349324&rfr_iscdi=true